Radient Pharmaceuticals Corp. (RPC) Appoints Seasoned Director to Head North American Sales
Radient Pharmaceuticals Corp. focuses on developing and commercializing diagnostic tests that assist physicians in answering important clinical questions related to early disease detection, including its Onko-Sure® In Vitro Diagnostic (IVD) cancer test. The company today announced it has appointed Gary Giarrantano as director of North American Sales for the company where he will be responsible for managing the company's sales and marketing strategy, operations and Onko-Sure(R) IVD product sales. Giarratano has more than 20 years of healthcare, sales and marketing leadership experience. He is recognized for his contributions in new market development for Carcinoembryonic Antigen (CEA), Prostate-Specific Antigen (PSA) and…